An imbalance of naive and memory/effector subsets and altered expression of CD38 on T lymphocytes in two girls with hyper-IgM syndrome

Clinical and Experimental Immunology

Volumn 136, Issue 2, 2004, Pages 291-296

  Costa Carvalho, B T ^a   Viana, M A ^a   Brunialti, M K C ^a   Kallas, E G ^a   Salomao, R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CD38; Cytokines; Hyper IgM; Naive memory cells; T lymphocytes

Indexed keywords

BCG VACCINE; CD38 ANTIGEN; CD4 ANTIGEN; CYTOKINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; ISONIAZID; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ANAMNESIS; ARTICLE; CELL COUNT; CELL FUNCTION; CHILD; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EFFECTOR CELL; ENTERITIS; FEMALE; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULINEMIA M; IMMUNE DEFICIENCY; INFANCY; INFANT; INTRACELLULAR SPACE; LABORATORY TEST; MEMORY CELL; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT INFECTION; T LYMPHOCYTE; TREATMENT OUTCOME;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD38; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD, PRESCHOOL; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INFANT; INTERFERON TYPE II; INTRACELLULAR FLUID; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2142654503     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02446.x     Document Type: Article

References (31)

1. Primary Immunodeficiency Diseases. Report of an IUIS Scientific Group. Clin Exp Immunol 1999; 118 (Suppl. 1):1-28.
2. Callard RE, Smith SH, Herbert J et al. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers. J Immunol 1994; 153:3295-306.
3. Korthauer U, Graf D, Mages HW et al. Defective expression of T-cell ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993; 361:539-41.
4. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, SaintBasile G. CD40 mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993; 361:541-3.
5. Beall GN, Ashman RF, Miller ME et al. Hypogammaglobulinemia in mother and son. J Allergy Clin Immunol 1980; 65:471-81.
6. Maródi L, Szabó I, Kalmár A. Immunoglobulin deficiency with increased immunoglobulin M in three siblings: effect of long-term immunoglobulin therapy. Eur J Pediatr 1988; 148:215-17.
7. Buscham A, Barnhart B, Shone S, Song C, Covey LR. A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndrome. J Immunol 2000; 164:2871-80.
8. Minegishi Y, Lavoie A, Cunningham-Rundles C et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 2000; 97:203-10.
9. Ferrari S, Giliani S, Insalaco A et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper-IgM. PNAS 2001; 98:12614-9.
10. Callard RE, Armitage RJ, Fanslow WC, Spriggs MK. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 1993; 14:559-64.
11. Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 1992; 3:101-21.
12. Oliva A, Quinti I, Scala E et al. Immunodeficiency with hyperimmunoglobulinemia M in two female patients is not associated with abnormalities of CD40 or CD40 ligand expression. J Allergy Clin Immunol 1995; 96:403-10.
13. Quezada A, Norambuena R, Gonzalez R, Ramos SM, Chávez A, González S. Non-X-linked hyperimmunoglobulin M syndrome with chronic intersticial pneumonitis. Invest Allergol Clin Immunol 2000; 10:375-9.
14. Cunningham CK, Bonville CA, Ochs HD et al. Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. J Pediatr 1999; 134:584-8.
15. McCloskey TW, Cavaliere T, Bakshi S et al. Immunophenotyping of T lymphocytes by three-color flow cytometry in healthy newborns, children and adults. Clin Immunol Immunopathol 1997; 84:46-55.
16. Erkeller-Yuksel FM, Deneys V, Yuksel B et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992; 120:216-22.
17. Galama JMD, Van Der Meer JWM, Munster IV, Weemaes CR. Relapsing hepatitis due to cytomegalovirus? J Infect 1991; 23:175-8.
18. Leiva LE, Junprasert J, Hollenbaugh D, Sorensen RU. Central nervous system toxoplasmosis with an increase proportion of circulating γδ T cells in a patient with hyper-IgM syndrome. J Clin Immunol 1998; 18:283-90.
19. Levy J, Espanol-Boren T, Thomas C et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997; 131:47-54.
20. Bonilla FA, Geha RS. CD154 deficiency and related syndromes. Immunol Allergy Clin North Am 2001; 21:65-90.
21. Fiorilli M, Giandomenico R, Paganelli R. et al. Hypogammaglobulinemia with hyper-IgM, severe T-cell defect, and abnormal recirculation of OKT4 lymphocytes in a girl with chronic lymphadenopathy. Clin Immunol Immunopathol 1986; 38:256-64.
22. Terada K, Kawano S, Yoshihiro K, Morita T. Natural killer cell activity in herpes zoster in children without underlying disease. Scand J Infect Dis 1993; 25:521-4.
23. Mizutani K, Ito M, Kamiya H, Sakurai M. Inhibition of varicella-zoster virus glycoprotein expression by peripheral blood mononuclear cells. Microbiol Immunol 1995; 39:217-20.
24. Brill KJ, Li Q, Larkin R, Canaday DH, Kaplan DR, Boom WH, Silver RF. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect Immun 2001; 69:1755-65.
25. Jackson DG, Bell JI. Isolation of a cDNA encoding the human CD38 (T10) molecule a cell surface glycoprotein with an unusual discontinous pattern of expression during lymphocyte differentiation. J Immunol 1990; 144:2811-15.
26. Lund F, Solvason N, Grimaldi JC, Parkhouse RM, Howard M. Murine CD38: an immunoregulatory ectoenzyme. Immunol Today 1995; 16:469-73.
27. Ferrero E, Malavasi F. The metamorphosis of a molecule: from soluble enzyme to the leukocyte receptor CD38. J Leuk Biol 1999; 65:151-61.
28. Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Metha K. Human CD38: a glycoprotein in search of a function. Immunol Today 1994; 15:95-7.
29. Levacher M, Hulstaert F, Dazza M. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol 1992; 90:376-82.
30. Uronen H, Callard RE. Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cells subsets. Clin Exp Immunol 2000; 121:346-52.
31. Clerici M, Shearer GM. - A TH1 - >TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14:107-11.